Showing results (841-850 of 1,005) with videos related to

Sort By:
Pageof 101
BMC Cancer|June 3, 2014
Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient's outcome in advanced colorectal cancer: the CORIOLAN studyAmelie Deleporte, Marianne Paesmans, Camilo Garcia, et al.
Clinical Breast Cancer|January 4, 2022
Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) TrialRafael Caparica, Yaohua Ma, Claudia De Angelis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumorsF A Eskens, A Awada, D L Cutler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Phase II study of E7070 in patients with metastatic melanomaJ F Smyth, S Aamdal, A Awada, et al.
Investigational New Drugs|August 4, 2010
A phase 1 study of BMS-275183, a novel oral analogue of paclitaxel given on a daily schedule to patients with advanced malignanciesElisabeth I Heath, Patricia Lorusso, Suresh S Ramalingam, et al.
IJID Regions|August 19, 2024
Predictors and outcomes of multi-drug-resistant gram-negative bacteremia in patients with cancer: A retrospective cohort study at a tertiary cancer center in OmanBassem Awada, Jorge Abarca, Sumbel Mumtaz, et al.
Journal of Clinical Pharmacology|January 7, 2011
Safety and pharmacokinetics of sorafenib combined with capecitabine in patients with advanced solid tumors: results of a phase 1 trialAhmad Awada, Thierry Gil, Nicolas Whenham, et al.
European Journal of Cancer (Oxford, England : 1990)|April 24, 2016
Results of the Belgian expanded access program of eribulin in the treatment of metastatic breast cancer closely mirror those of the pivotal phase III trialPhilippe Aftimos, Laura Polastro, Lieveke Ameye, et al.
Clinical Breast Cancer|July 22, 2025
Characteristics, Treatment Patterns and Clinical Outcomes of Women with Maghreb Origin and Diagnosis of Breast Cancer: A Single-Center, Retrospective Cohort StudyChiara Dauccia, Diogo Martins-Branco, Michel Moreau, et al.
Journal of Chemotherapy (Florence, Italy)|August 3, 2013
Comparison of a gene expression profiling strategy to standard clinical work-up for determination of tumour origin in cancer of unknown primary (CUP)Felipe Ades, Evandro de Azambuja, Gedske Daugaard, et al.
Pageof 101